There were 947 press releases posted in the last 24 hours and 186,103 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
China NMPA Approves QINLOCK® (Ripretinib) for Treatment of Advanced Gastrointestinal Stromal Tumors (GIST)

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image